According to researchers, polypill, which is an inexpensive pill containing aspirin, a blood thinner, a medicine that lessens cholesterol and blood pressure, and two medications to reduce hypertension, reduces the threat of serious heart failures and strokes by one-third.
It was observed, according to a report published in The Lancet, during clinical trial, how polypill proved to be considerably effective when used on individuals who had no history a cardiovascular ailment, cutting down the number of serious attacks by 40%.
Polypill proved to be only half as effective when used on individuals who had previously had heart ailments or strokes, relative to the control group with no prior ailments. They received guidance on a healthy lifestyle without any medications.
Nearly 50% of the individuals were administered the polypill (between years 2011 and 2013) and advised on how to make changes in their lifestyle for better, while the other half were just given advice.
According to the research, this pill considerably reduced bad cholesterol levels but had only a minor impact on blood pressure. The polypill was administered to people who were more than 50 years of age, not taking into account whether they had a history of heart ailments or not.
The idea behind the pill was put forward more than 20 years ago in the shape of a less complex, inexpensive pill which treats cardiovascular ailment, which generally needs to be taken down by numerous medications.
Dr. Nizal Sarrafzadegan, from the Isfahan University of Medical Sciences, Iran said, “Given the polypill’s affordability, there is considerable potential to improve cardiovascular health and to prevent the world’s leading cause of death.”
In spite of its evident promise, the polypill has not yet to been tested on a larger scale over an increased period of time.